Hecker M, Bayer M, Krombach G A, Sommer N
Medizinische Klinik II, Universitätsklinikum Gießen und Marburg, Standort Gießen, Mitglied des Deutschen Zentrums für Lungenforschung (DZL), Justus-Liebig-Universität, Gießen, Deutschland.
Medizinische Klinik I, Universitätsklinikum Gießen und Marburg, Standort Gießen, Gießen, Deutschland.
Med Klin Intensivmed Notfmed. 2025 Apr;120(3):256-269. doi: 10.1007/s00063-025-01249-w. Epub 2025 Mar 6.
Acute pulmonary embolism is a common and potentially fatal condition in intensive care and emergency medicine. The mortality rate within the first few hours of its occurrence is particularly high; thus, even in the event of clinical suspicion, immediate initiation of diagnostics and treatment is crucial. The current European and national guidelines on acute pulmonary embolism provide valuable and practical support on this topic and form the basis of this review. A particular focus lies in the presentation of a risk-adapted and algorithm-based diagnostic and therapeutic approach. In particular, there are new recommendations regarding risk stratification and differentiated therapy, which are discussed in this article.
急性肺栓塞在重症监护和急诊医学中是一种常见且可能致命的病症。其发生后的最初几个小时内死亡率特别高；因此，即使临床怀疑，立即启动诊断和治疗至关重要。当前欧洲和各国关于急性肺栓塞的指南为该主题提供了有价值且实用的支持，并构成了本综述的基础。特别关注的是提出一种基于风险和算法的诊断及治疗方法。特别是，本文讨论了有关风险分层和差异化治疗的新建议。
